Cargando…
Assessing lead time bias due to mammography screening on estimates of loss in life expectancy
BACKGROUND: An increasingly popular measure for summarising cancer prognosis is the loss in life expectancy (LLE), i.e. the reduction in life expectancy following a cancer diagnosis. The proportion of life lost (PLL) can also be derived, improving comparability across age groups as LLE is highly age...
Autores principales: | Syriopoulou, Elisavet, Gasparini, Alessandro, Humphreys, Keith, Andersson, Therese M.-L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867879/ https://www.ncbi.nlm.nih.gov/pubmed/35197123 http://dx.doi.org/10.1186/s13058-022-01505-3 |
Ejemplares similares
-
Estimating latent, dynamic processes of breast cancer tumour growth
and distant metastatic spread from mammography screening data
por: Gasparini, Alessandro, et al.
Publicado: (2022) -
Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England
por: Syriopoulou, Elisavet, et al.
Publicado: (2017) -
Illustration of different modelling assumptions for estimation of loss in expectation of life due to cancer
por: Andersson, Therese M.-L., et al.
Publicado: (2019) -
Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort
por: Strandberg, Rickard, et al.
Publicado: (2022) -
Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy
por: Paci, Eugenio, et al.
Publicado: (2006)